Modern medicines have positively contributed to public health and changed the ways human diseases are prevented and treated. Yet, most drugs are not without side effects. Adverse drug reactions (ADRs) rank among the leading causes of morbidity and mortality worldwide. The current paradigm of drug development can detect only the most common ADRs in clinical trials.
From https://medicalxpress.com/news/2019-04-panvigilancea-strategy-biomarkers-clinical-trials.html
from https://heidifrost.blogspot.com/2019/04/panvigilancea-strategy-to-integrate.html
from
https://heidifrost0.tumblr.com/post/183884323402
From https://jasonhart1.blogspot.com/2019/04/panvigilancea-strategy-to-integrate.html
from
https://jasonhart01.wordpress.com/2019/04/02/panvigilance-a-strategy-to-integrate-biomarkers-in-clinical-trials-to-enhance-drug-safety/
No comments:
Post a Comment